KYNB CIK: 921299

Kyntra Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
222
FY22:
120
FY23:
42.8
FY24:
14.1
FY25:
5.88
(positive)
Change from FY21 to FY25
millions USD
FY21:
−289
FY22:
−301
FY23:
−323
FY24:
−150
FY25:
−45.9
(positive)
Change from FY21 to FY22
millions USD
FY21:
−274
FY22:
−283
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−291
FY22:
−295
FY23:
−323
FY24:
−153
FY25:
−58.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−290
FY22:
−294
FY23:
−284
FY24:
−47.6
FY25:
183

All amounts in millions USD Data sources:SEC EDGARTwelve Data